DCGI approves KEYTRUDA to treat triple negative breast cancer, renal cell carcinoma
KEYTRUDA is now approved for 14 indications across eight tumour types in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
triple-negative breast cancer
FDA approves new therapy for triple negative breast cancer that has spread, not responded to other…
The FDA granted approval of Trodelvy to Immunomedics